Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Patenting the Recombinant Products of Biotechnology and Other Molecules

by Phillipe G. Ducor
Sold out
₹21,632.00
Original price ₹21,632.00
Original price ₹21,632.00
₹21,632.00
Current price ₹21,632.00

Imported Edition - Ships in 18-21 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Hardcover
  • ISBN13: 9789041106988
  • Binding: Hardcover
  • Subject: N/A
  • Publisher: Kluwer Law International
  • Publisher Imprint: Kluwer Law International
  • Publication Date:
  • Pages: 208
  • Original Price: USD 207.0
  • Language: English
  • Edition: N/A
  • Item Weight: 459 grams
  • BISAC Subject(s): Intellectual Property / General

This work examines the requirements for patentability in the context of biotechnology, with a special focus on the non-obviousness requirement. It analyses non-obviousness as applied to biotechnology molecular products via a review of the relevant case law. The work begins with a typology of recombinant inventions, useful in determining ultimate non-obviousness and patentability. It distinguishes three categories of recombinant products: Translation' inventions, obtained by entering a known molecular information into a known process Molecular modification' products, obtained by modifying prior art molecules Combination' inventions, obtained by combining several known functional molecular units. Recognizing the risk that many translation inventions will be considered obvious upon maturation of the underlying technology, the author examines possible alternatives for protection. The author critiques and ultimately rejects the idea of lowering the non-obviousness standard, elected by the Federal Circuit in In re Deuel. The work describes several current examples of sui generis intellectual property rights and also examines a no action' scenario, emphasizing that the rapid changes occurring in biotechnology might ultimately make the current problem obsolete. Patenting the Recombinant Products of Biotechnology and Other Molecules also addresses broader issues such as the growing secrecy in basic science and its link to the disappearance of a clear distinction between basic and applied research. Patent law practitioners, inventors and researchers in the biotech world, and their advisors will appreciate this detailed, thorough analysis on this cutting-edge topic.

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us